In the unlisted market, the company s shares are trading with a marginal premium of Rs 2, which indicates a flat or even a discounted debut at the bourses. The IPO comprised a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares.
Entero Healthcare IPO comprises a fresh equity issue of Rs 1,000 crore and an OFS of up to 47.69 lakh shares. Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, and Deepesh T Gala, among others, will offload shares under the OFS. The shares are trading with a marginal premium of Rs 10 in the grey market.
The Street will see a flurry of listings, four of them in the mainboard segment. Three IPOs of Rashi Peripherals, Jana SFB and Capital SFB opened last week and closed for subscription. The listings of these three public offers are scheduled for next week.
“Our business model is very simple. We are one of the largest distributors of healthcare products in this country. Basically, we buy from 1900 different companies today and supply to around eighty-one-and-a-half thousand retail pharmacies and three-and-a-half thousand hospitals.”